Present status and future perspectives of heart transplantation.
暂无分享,去创建一个
Abul Kashem | T. Guy | A. Kashem | Y. Toyoda | T Sloane Guy | Yoshiya Toyoda | Y. Toyoda
[1] N. Smedira,et al. Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study , 2007, Clinical transplantation.
[2] D. Freimark,et al. Hearts from donors with chronic alcohol use: a possible risk factor for death after heart transplantation. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] L. Klein,et al. Coronary Endothelial Dysfunction After Heart Transplantation Predicts Allograft Vasculopathy and Cardiac Death , 2002, Circulation.
[4] L. Yeatman,et al. Effect of pravastatin on outcomes after cardiac transplantation. , 1995, The New England journal of medicine.
[5] M. Suchard,et al. Luminex-based virtual crossmatching for renal transplantation in South Africa. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[6] J. Hosenpud,et al. THE RESULTS OF CARDIAC RETRANSPLANTATION: AN ANALYSIS OF THE JOINT INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION/UNITED NETWORK FOR ORGAN SHARING THORACIC REGISTRY , 2000, Transplantation.
[7] Marshall I Hertz,et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] David O. Taylor. Cardiac transplantation: drug regimens for the 21st century. , 2003, The Annals of thoracic surgery.
[9] W. S. Ring,et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. , 2002, Circulation.
[10] L. Shaw,et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. , 1996, Journal of the American College of Cardiology.
[11] T. Eastlund. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. , 1995, Cell transplantation.
[12] A. Wechsler,et al. Heart transplantation. , 1985, Investigative radiology.
[13] M. Olivari,et al. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail. , 1996, Journal of the American College of Cardiology.
[14] M. R. Mickey,et al. Long-term survival of kidney grafts. , 1989, Transplantation proceedings.
[15] T. Merigan,et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.
[16] L. Chatenoud,et al. The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells. , 1990, Transplantation.
[17] A. Leung,et al. Invasive aspergillosis in the setting of cardiac transplantation. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] M. Billingham. Histopathology of graft coronary disease. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] M C Oz,et al. Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.
[20] R. Starling,et al. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[21] S. Normand,et al. Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.
[22] D. Burkhoff,et al. Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy , 2003, Circulation.
[23] D. Renlund,et al. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[24] I. Bassanetti,et al. Evolution of untreated mild rejection in heart transplant recipients. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[25] B. Griffith,et al. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. , 1988, The Journal of thoracic and cardiovascular surgery.
[26] C. S. Campbell,et al. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. , 1995, Thorax.
[27] E. Trulock,et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] B. Susskind,et al. Prediction of Crossmatch Outcome of Highly Sensitized Patients by Single and/or Multiple Antigen Bead Luminex Assay , 2006, Transplantation.
[29] A. Zachary,et al. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. , 2009, Human immunology.
[30] D. Renlund,et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[31] S. Berger,et al. Practical application of the virtual crossmatch , 2007, Pediatric transplantation.
[32] L. Siegel,et al. Physiology of the Transplanted Heart , 1995, International anesthesiology clinics.
[33] G. Bhat,et al. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] Transmission of hepatitis C virus by organ transplantation. , 1991, The New England journal of medicine.
[35] L. Miller,et al. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation Results of a prospective, randomized multicenter trial , 1996 .
[36] O H Frazier,et al. Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.
[37] G. Fonarow,et al. Use of two recipient lists for adults requiring heart transplantation. , 2003, The Journal of thoracic and cardiovascular surgery.
[38] J. Butany,et al. An approach to endomyocardial biopsy interpretation , 2006, Journal of Clinical Pathology.
[39] R. Kerman. Understanding the sensitized patient. , 2007, Heart failure clinics.
[40] R. P. Cochran,et al. Ambulatory intraaortic balloon pump use as bridge to heart transplant. , 2002, The Annals of thoracic surgery.
[41] G. Mudge,et al. Serial assessment of left ventricular function and mass after orthotopic heart transplantation: a 4-year longitudinal study. , 1992, Journal of the American College of Cardiology.
[42] M. Oz,et al. Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. , 2001, The Annals of thoracic surgery.
[43] R. John,et al. Immunobiologic consequences of assist devices. , 2003, Cardiology clinics.
[44] M. Mehra,et al. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[45] M. Fishbein,et al. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[46] M. Hertz. The Registry of the International Society for Heart and Lung Transplantation--Introduction to the 2012 annual reports: new leadership, same vision. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[47] L. Miller,et al. Infection after heart transplantation: a multiinstitutional study , 1994 .
[48] E. Wellnhofer,et al. Reproducibility of serial intravascular ultrasound measurements in patients with angiographically silent coronary artery disease after heart transplantation , 2000, Coronary artery disease.
[49] D. Cooley,et al. Cardiac transplantation. , 1986, The Surgical clinics of North America.
[50] A. Zachary,et al. Detecting and monitoring human leukocyte antigen-specific antibodies. , 2008, Human immunology.
[51] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[52] R. Guttmann,et al. Evidence for complement-induced endothelial injury in vivo: a comparative ultrastructural tracer study in a controlled model of hyperacute rat cardiac allograft rejection. , 1982, The American journal of pathology.
[53] L. Sharples,et al. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[54] D. Norman. Mechanisms of Action and Overview of OKT3 , 1995, Therapeutic drug monitoring.
[55] N. Banner,et al. C4d Fixing, Luminex Binding Antibodies—A New Tool for Prediction of Graft Failure After Heart Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[56] R. Rubin. Prevention and treatment of cytomegalovirus disease in heart transplant patients. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[57] D. Freimark,et al. Donors with a history of cocaine use: effect on survival and rejection frequency after heart transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[58] W. S. Ring,et al. Consensus Conference Report , 2002 .
[59] J. Farmer,et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. , 1991, The American journal of cardiology.
[60] M. Gómez-Sánchez,et al. A Randomized Multicenter Comparison of Basiliximab and Muromonab (OKT3) in Heart Transplantation: SIMCOR Study , 2006, Transplantation.
[61] D C Naftel,et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[62] R. Körfer,et al. Differential indication for mechanical circulatory support following heart transplantation , 2001, Intensive Care Medicine.
[63] Y. Toyoda,et al. Alemtuzumab Induction Prior to Cardiac Transplantation with Lower Intensity Maintenance Immunosuppression: One‐Year Outcomes , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[64] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[65] W. S. Ring,et al. Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[66] S. Chu,et al. Heart transplantation with marginal recipients and donors. , 1999, Journal of the Formosan Medical Association = Taiwan yi zhi.
[67] F. Schoen,et al. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? , 1995, Circulation.
[68] S. Jeong,et al. Comparison of the Effects of Nicardipine and Sodium Nitroprusside for Control of Increased Blood Pressure after Coronary Artery Bypass Graft Surgery , 2004, The Journal of international medical research.
[69] S. Hunt. Taking heart--cardiac transplantation past, present, and future. , 2006, The New England journal of medicine.
[70] M. Hammond,et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.
[71] J. Fang,et al. Rise of the machines--left ventricular assist devices as permanent therapy for advanced heart failure. , 2009, The New England journal of medicine.
[72] S. Lundin,et al. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[73] L. Miller,et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[74] J. Hill,et al. Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. , 2003, The Journal of thoracic and cardiovascular surgery.
[75] R. Montgomery,et al. Defining unacceptable HLA antigens. , 2008, Current opinion in organ transplantation.
[76] L. Miller. Treatment of cardiac allograft rejection with intravenous corticosteroids. , 1990, The Journal of heart transplantation.
[77] O. Frazier,et al. Sudden cardiac death in cardiac transplant recipients. , 1996, Circulation.
[78] A. Keogh. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. , 2005, Transplantation proceedings.
[79] P. Ponikowski,et al. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. , 2000, European heart journal.
[80] A. Cribier,et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. , 2000, Transplantation proceedings.
[81] Hhs Centers for Medicare Medicare Services. Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule. , 2007, Federal register.
[82] J. Kobashigawa,et al. INHALED NITRIC OXIDE FOR PULMONARY HYPERTENSION AFTER HEART TRANSPLANTATION , 2001, Transplantation.
[83] P. Cremaschi,et al. Pneumocystis carinii pneumonia in heart transplant recipients , 1993, Infection.
[84] R. Novick,et al. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[85] K. Mussatto,et al. The virtual crossmatch – A screening tool for sensitized pediatric heart transplant recipients , 2006, Pediatric transplantation.
[86] H. Valantine,et al. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. , 2005, Transplantation proceedings.
[87] S. Hunt,et al. The changing face of heart transplantation. , 2008, Journal of the American College of Cardiology.
[88] G Opelz,et al. CORRELATION OF HLA MATCHING WITH KIDNEY GRAFT SURVIVAL IN PATIENTS WITH OR WITHOUT CYCLOSPORINE TREATMENT: FOR THE COLLABORATIVE TRANSPLANT STUDY , 1985, Transplantation.
[89] J. Barkun,et al. Antithymocyte Globulin Induction Allows a Prolonged Delay in the Initiation of Cyclosporine in Heart Transplant Patients with Postoperative Renal Dysfunction , 2004, Transplantation.
[90] P. McCarthy,et al. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[91] A. Boyle,et al. Recipient selection and management. , 2004, Seminars in thoracic and cardiovascular surgery.
[92] D. Driscoll,et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. , 1995, Circulation.
[93] C. Sivathasan. Experience with cyclosporine in heart transplantation. , 2004, Transplantation proceedings.
[94] R. Gajarski,et al. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[95] J. Friedewald,et al. Tailoring Antibody Testing and How to Use it in the Calculated Panel Reactive Antibody Era: The Northwestern University Experience , 2008, Transplantation.
[96] E. Hammond,et al. Vascular rejection and its relationship to allograft coronary artery disease. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[97] Silviu Itescu,et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[98] Uretsky Bf. Physiology of the transplanted heart. , 1990 .
[99] M. Kass,et al. Cardiac allograft vasculopathy: pathology, prevention and treatment , 2006, Current opinion in cardiology.
[100] B. Griffith,et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[101] E. Cantu,et al. Role of Flow Cytometry to Define Unacceptable HLA Antigens in Lung Transplant Recipients with HLA-Specific Antibodies , 2006, Transplantation.